A method for determining valproic acid in human whole blood and urine via gas chromatography-mass spectrometry and small-scale inter-laboratory trial

Leg Med (Tokyo). 2022 Nov:59:102133. doi: 10.1016/j.legalmed.2022.102133. Epub 2022 Aug 17.

Abstract

A simple and cost-effective method for analyzing valproic acid (VPA) in biological samples was developed. VPA was extracted in methyl tertiary-butyl ether (MTBE) and derivatized using trimethylsilyldiazomethane. The MTBE extract was analyzed by gas chromatography-mass spectrometry (GC-MS). The extraction recovery in human whole blood and urine was over 90 %, with good linearity in the range of 1.0 to 250 µg/mL of VPA. The RSD for 2.0, 20, and 200 μg/mL VPA in whole blood ranged from 0.9 to 4.7 % for intra-day and 1.5 to 5.9 % for inter-day. The RSD for 2.0, 20, and 200 μg/mL VPA in urine ranged from 1.9 to 2.6 % for intra-day and 1.2 to 2.9 % for inter-day. As a preliminary cross-validation study, a cross-check was conducted using blinded concentration samples. The results demonstrated that the assay data of the two laboratories were comparable.

Keywords: GC-MS; Trimethylsilyldiazomethane; Urine; Valproic acid; Whole blood.

MeSH terms

  • Gas Chromatography-Mass Spectrometry / methods
  • Humans
  • Methyl Ethers*
  • Valproic Acid*

Substances

  • Valproic Acid
  • methyl tert-butyl ether
  • Methyl Ethers